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Abstract Medical case reports provide an important example of data journeying: 
they are used to collect data and make them available for re-use to others in the field 
including clinicians, biomedical researchers, and health policymakers. In this paper, 
I explore how data journey in case reports, with particular focus on the earliest 
stages of the process, namely from creation and publication of case reports to the 
initial re-uses of them and data within them. I investigate key themes relating to case 
reporting and re-use, including factors which seem to smooth the path along which 
the data captured by a case report journey via broader citation patterns and detailed 
qualitative analysis of highly re-used case reports. This analysis reveals some of the 
key factors associated with the case reports whose data have greater amounts of 
journeying including publication in a general medical journal; that the data have 
broader implications and evidential value for topical or even urgent issues for 
instance in public health; and use in the case report of multiple research methods or 
concepts from diverse subfields. These findings along with standardization of case 
reporting are shown to have epistemological implications, particularly for how we 
understand the journeying of data.
1  Introduction
Data never stand on their own: they are gathered and become accessible via differ-
ent forms of “packaging” (Ankeny 2010; Leonelli 2010, 2016) and travel over space 
and time. These journeys associated with their use and re-use in various contexts 
shape how they are understood, interpreted, and subsequently utilized. The issues 
associated with curation, imposing ontologies, and establishing metadata via online 
databases are well recognized, including the resulting epistemological limitations 
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(Leonelli 2016). Standardization of data is a critical part of such processes and is 
extremely complex even where the data in question are relatively simple (such as 
genomic sequencing data in organism-based databases, see Leonelli and Ankeny 
2012), let alone in fields where data are highly heterogeneous (e.g., in this volume 
see the chapters by Halfmann, Parker, Ramsden, and Wylie).
Clinical research is a domain of scientific practice where data often are extremely 
complex and collected in highly variable and non-standardized ways. The com-
plexities associated with the data collected typically arise not because of the content 
of the data but because of our (high) level of interest in the details and the mixture 
of subjective and objective types of information in play whenever the main focus is 
on humans and particularly patients. Various types of data can be more easily stan-
dardized than others, for instance those collected in randomized controlled trials 
(RCTs), which can be easily aggregated using meta-analysis or similar. However 
other types of clinical data are much more diverse in terms of quantity, quality, 
provenance, means of production, attached metadata, and so on.
Medical case reports are a particularly striking example: among other purposes, 
they are used to collect data and make them available for re-use by others including 
clinicians, biomedical researchers, and health policymakers (for other uses, see e.g. 
Ankeny 2010, 2014, 2017a). Case reports are an ideal focus for exploring of how 
data “journey” at their earliest stages. They do not tend to cover great distances in 
any literal sense, but instead move from one context to another and thus allow 
exploration and development of understanding via application in new domains.
In this paper, I explore how data journey in case reports with particular focus on 
the earliest stages of the process, namely from creation and publication of case 
reports to the initial re-uses of them and data within them. Following presentation 
of background on medical case reports, I investigate key themes relating to case 
reporting and re-use, including factors that seem to smooth the path of the journey 
along which the data travel, via broader citation patterns and detailed qualitative 
analysis of highly re-used case reports. This analysis reveals some of the key factors 
associated with the valuing of data captured by case reports by those in the broader 
biomedical and health communities, as well as allowing reflections on how and 
when case reports are most useful and how standardization of case reporting might 
support the journeying of data.
As in the historical sciences, much of what is contained in medical case reports 
is contingent. In both fields, narratives are particularly useful ways of accounting 
for contingent outcomes by providing detailed data relating to them since narratives 
allow capture of rich descriptions that permit the envisioning of alternative possi-
bilities or relationships.1 Medical case reporting also involves processes of toggling 
back and forth between individual instances (observations on a specific patient) and 
the generalizations that might follow from them, if only implicitly.2 Thus this 
1 See Beatty 2016, 2017 on issues relating to contingency as well as what makes something 
narrative-worthy.
2 On similar processes in natural history, see Terrall 2017.
R. A. Ankeny
61
account also has relevance for the historical sciences and other sciences which 
depend closely on contingent and local observational data.
2  Background: What Are Medical Case Reports?
Medical case reports have been utilized for centuries to record and disseminate 
unusual presentations of illness that cannot be readily identified or that do not eas-
ily map onto recognized clinical conditions. Using a detailed narrative format,3 
they outline the diagnosis, treatment, and outcomes typically of a single patient (or 
a small series of patients) with a focus on practice-based observations and clinical 
care, rather than the results of RCTs or other experimental methodologies. One 
goal of case reporting is to capture data on specific instances of phenomena includ-
ing many details that may not be immediately relevant, but may prove to be: the 
data do not have an immediate or definite purpose or target, but are collected 
because of their potential and future evidential value, which often is not clear when 
the case report is written or published. Thus these data (and the case report itself) 
are made available for re-use over time as subsequent instances of similar illnesses 
arise or as the data within the case report becomes relevant for another purpose, and 
so can be systematically combined into larger datasets and hence journey beyond 
their original domain.
Unlike RCTs or similar, the data typically contained in case reports are highly 
non-standardized, and include a mixture of quantitative and qualitative information. 
Accordingly, they are treated as one of the lowest types of evidence in the hierarchy 
associated with the evidence-based medicine (EBM) movement (Nissen and Wynn 
2012). Some critics even have argued that highlighting the rare and unusual (termed 
by them “anecdotal”) is dangerous, because they can lead clinician-readers to mis-
taken interpretations about what they are seeing in seeing in their patients and what 
is likely (Hoffman 1999) or that they rely on specious claims made by clinicians 
who wish to get published but without doing the required research (McGee 2006). 
It also has been documented that case reports do not receive nearly as many cita-
tions as meta-analyses or randomized controlled trial (Patsopoulos et al. 2005), and 
are read far less often (Leopold 2015). Hence some journals have limited the num-
ber of case reports that they publish, imposed much more detailed and stringent 
guidelines, or even stopped publishing them altogether. From their point of view, to 
borrow a phrase, “the plural of anecdote is not data” (Leopold 2015, 3074).
Advocates of case reports defend their use for particular types of purposes (e.g., 
Godlee 1998; Vandenbroucke 1999, 2001; Wright and Kouroukis 2000; Carey 2006; 
Smith 2008; Smalheiser et al. 2015; Rison et al. 2017): first, they can serve as the 
basis of hypotheses and direct future clinical research especially about the efficacy 
3 On narratives in case reports, see especially Hurwitz 2017; on narrative in medicine, see Gygax 
and Locher 2015; Hurwitz and Bates 2016.
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of interventions, side effects of certain treatments or drugs, and aspects of clinical 
practice relating to individualized treatment (see Ankeny 2014, 2017a). Case reports 
have proven useful for identifying adverse and beneficial effects and recognizing 
new or rare diseases or unusual manifestations of common diseases; an oft-cited 
example of the success of case reporting is the recognition of the relationship 
between use of the drug thalidomide by pregnant women and congenital abnormali-
ties in newborns (McBride 1961; Lenz 1962). Case reports can serve as a type of 
evidence even in EBM when used in the appropriate manner (Jenicek 2001) and can 
also be useful in clinical education (Cabán-Martinez and García-Beltrán 2012), par-
ticularly given the dominance of problem-based learning approaches in medicine. 
Finally, there is some evidence that case reports can make significant contributions 
to medical research planning (Albrecht et al. 2005).
Case reports account for a rapidly growing number of medical publications and 
an increasing number of dedicated journals in recent years, with at least 160 case 
reports journals from 78 publishers documented as of mid-2015 (for a useful sum-
mary, see Akers 2016, Table 1 available online), with observers commenting that 
there has been a “renaissance of the case reporting literature” (Smalheiser et  al. 
2015, 171). More generally in the field of medicine considered as a whole, the num-
ber of MEDLINE-listed case reports is said to substantially exceed the number of 
published clinical studies (Kiene et al. 2013). The newer journals tend to be open 
access and range from having a focus on general medical issues to accounts of case 
reports in more specialized subfields. Unfortunately, predatory publishing practices 
are particularly rampant among case report journals (Akers 2016), with nearly 50% 
of publishers engaging in questionable publishing practices. In addition, few have 
impact factors, in part because of the infrequency with which case reports are cited, 
but nearly half of the journals (as of mid-2015) are indexed in PubMed (Akers 
2016), making them accessible to clinicians and researchers and for analysis of the 
types performed in the current paper.
Unlike other parts of medical training and publication (e.g., differential diagnos-
tic processes or mortality and morbidity reporting, see Bosk 1979), the processes of 
recording this type of historical data generally have not been made consistent or 
standardized. Thus case reports have been viewed by many within the field as insuf-
ficiently rigorous for aggregation for data analysis which would be rigorous enough 
to inform research design and allow data to journey to new domains to permit com-
parisons across diverse contexts including different sociocultural settings. 
Traditional approaches to gathering data via case reports make it difficult to locate 
and re-use relevant data despite considerable technological improvements related to 
the rise of open access and internet-based systems.
Out of recognition of many of these limitations, consensus-based international 
guidelines have been developed, called the “CAse REport” or CARE guidelines 
(Gagnier et al. 2013), to increase the completeness in the presentation of published 
case reports, create more comparability between the data contained in case reports 
particularly with regard to potential therapeutic interventions and outcomes, and 
generate more transparency for patients and practitioners, and in turn to inform 
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clinical practice guidelines. When adopted by a journal, these types of guidelines 
have been argued to be associated with an increase in the completeness of the infor-
mation published (e.g., Turner et al. 2012) and hence can be viewed as critical prag-
matic constructs.
The CARE guidelines are a 13-item checklist outlining basic reporting require-
ments for published case reports, provided in a structured manner. The key goal is 
to increase completeness and transparency in published case reports. The authors 
stress that they “attempted to strike a balance between adequate detail and the con-
cise writing that is one of the appealing characteristics of a case report” (Gagnier 
et  al. 2013, 4).4 As discussed elsewhere (Ankeny 2017b), these guidelines are 
extremely revealing with regard to the underlying epistemology of case reporting 
particularly in the current era of dedicated journal outlets which have considerable 
investment in establishing case reports as a valid form of evidence. For the purposes 
of this paper, I do not analyze them in any detail particularly because their promul-
gation has been quite recent but do use some of the issues highlighted in the guide-
lines in my analysis of re-use patterns.
3  Detecting Patterns and Themes in Case Reporting 
and Re-use
3.1  Broader Patterns of Re-use
One of the main potential benefits of publishing case reports (and providing the 
necessary infrastructures to make them more accessible) is so they can be re-used 
by others who come across similar phenomena particularly in clinical settings, or so 
that the observational data can be used as the basis for initiating various types of 
research. Hence it is useful to look at the broader patterns of re-use to get a sense of 
the uptake of medical case reports.
More generally, it must be noted that citation analysis may severely underesti-
mate the impact of clinical-oriented research in certain fields particularly in com-
parison to basic research (e.g., Van Eck et al. 2013) and case reports specifically are 
cited at a negligible rate compared to other types of publications (Patsopoulos et al. 
2005). However for the purposes of this paper, a focus on published literature is 
appropriate because I am primarily interested in explicit re-uses of data captured in 
4 This structure also aims to capture “useful” information including that required by the 
U.S. Department Health and Human Services to demonstrate so-called “meaningful use” of certi-
fied electronic health records, which in turn is required by some private insurers for physicians to 
for health providers to quality for certain types of performance incentives. Although intriguing to 
consider the epistemological impacts of these social and financial incentives, an analysis of the 
interplay between these requirements and the content of case reporting guidelines is beyond the 
scope of this paper.
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case reports; note that this approach of necessity will fail to capture negative 
instances, that is, where a case report was accessed and utilized but found not to be 
relevant to the current problem or phenomenon under examination, in similar ways 
to the type of publication bias that has been well recognized with regard to negative 
results (e.g., Kicinski et al. 2015). Article usage statistics (available via many jour-
nals and databases) might well provide more accurate quantitative information that 
could be compared across case reports but would fail to allow any assessment of 
whether or how a case report is being re-used.
Tracking re-use of medical case reports is plagued with technological difficul-
ties, particularly when assessing case reports via citations across all types of jour-
nals and medical subfields: for instance although PubMed5 indexes nearly half of 
the journals that publish case reports, excludes most that are likely to be predatory 
journals (Akers 2016), and provides a “case reports” filter, it does not allow analysis 
of articles by number of citations (similar limitations occur with Embase, another 
major medical database). An additional issue is that there are inaccuracies in the 
tagging of publications as “case reports” (see note 6 below for a rough estimate of 
the rate of inaccuracy). Even tracing case report patterns by journal by focusing on 
the dedicated journals is complicated by the fact that several major case report jour-
nals have changed name over time and full datasets are thus not readily available.
Hence I used two strategies to analyze case reporting and re-use over the past 
25 years: (1) a broader strategy allowing general patterns of re-use (using citations 
as a proxy) to be visualized; and (2) a more specific strategy focused on highly cited 
case reports. The temporal window of 1997–2017 was selected to permit inclusion 
of both the newer journals focused on case reports as well as more traditional jour-
nals which publish case reports; it also allows medium- and longer-term re-use to be 
tracked, since as the analysis reveals, re-use often only occurs over considerable 
periods of time.
For the first broader search, Web of Science was utilized using a case report 
focused strategy for medically related fields6 to extract data for the years 1997–2017, 
which generated a total of 108,348 case reports. Just over 30% of these reports have 
no citations to date, and just over 17% have between one and ten citations since time 
of publication. A second analysis used the Medline subset within Web of Science, 
5 PubMed is a free search engine which primarily allows access to the MEDLINE database of refer-
ences and abstracts on life sciences and biomedical topics, which in turn is managed by the United 
States National Library of Medicine at the National Institutes of Health as part of the Entrez sys-
tem of information retrieval.
6 This search was performed on 14 November 2018 by utilizing Web of Science Core Collection to 
search for all items tagged as topic = “case report∗” for the years 1997–2017, which generated a 
list of all items tagged as case reports from more generalized journals. This set was then supple-
mented by inclusion of all publications in case report-focused journals for the same time period 
(identified by explicit inclusion of “case report” or similar in the journal titles, and drawing on the 
list published in Akers 2016). These sets were combined and then narrowed to include only those 
with topic = “human∗” or “patient∗”, and by excluding publications coded to non-medical catego-
ries. The publications were then run through Clarivate InCites to obtain rates of citation.
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to perform a search for case reports for the years 1997–2017.7 The results were 
102,195 articles, of which only 98 (slightly more than .09%) of the publications 
verified to be case reports8 were highly cited in their respective field as of March/
April 2018 (i.e., they received enough citations to place them in the top 1% of their 
academic field based on a highly cited threshold for the field and publication year); 
of these publications, only four were published in the past 2 years and received 
enough citations to place them in the top 0.1% of papers in their respective aca-
demic field. Thus these findings echo previous analyses of the relative neglect of 
uptake of case reports, but do permit us to focus on those that may have resulted in 
important instances of re-use.
The highly cited case reports do share certain characteristics: first, they tend to 
appear in highly popular, general medical journals (e.g., The New England Journal 
of Medicine), which have extremely large readerships. They also cover one of three 
main topics broadly defined, namely non-randomized and non-controlled trials of 
experimental drugs or therapies on individuals or very small groups of patients, 
often on a compassionate or emergency basis; epidemiological or other features of 
emerging or novel diseases that are typically infectious in nature; and characteriza-
tion of underlying mutated genetic sequences of disease-related phenotypes or pro-
cesses at other levels (such as tumors). Less frequent topics include adverse effects 
of or reactions to therapies of various types; reporting of new illegal drug use and 
effects; and longer-term outcomes of novel surgical procedures, particularly organ 
and other transplants. Despite all of these publications being considered to be highly 
cited, there is no particularly robust correlation between year of publication and the 
number of citations, and the range in the number of citations is large, from nearly 
1500 for a 2011 paper on using modified T-cells to treat leukemia, to 15 for a 2017 
paper published in a more narrow subfield, toxicology, focused on episodes of 
intoxication via a new synthetic opioid.
Although these broader trends give us hints about how data can journey to new 
domains via case reports, more qualitative analysis helps to reveal precisely what 
travels from early stage case reports and what roles such data journeying serves. 
Hence in the following sections, a series of highly cited case reports are analyzed 
to provide insights into the valuing of data captured by case reports and what fac-
tors are associated with re-use. I have opportunistically selected two case reports 
to explore which have particularly interesting patterns of data re-use but have 
attempted to represent two of the main types of case reporting captured in the 
quantitative analysis above.
7 This search was performed by selecting “case report” in the document type field for the years 
1997–2017, then limiting to core clinical journals and to humans (17 July 2018).
8 The original set that was automatically generated on 17 July 2018 included 118 articles, of which 
20 (17%) were determined not to be case reports based on manual review of abstracts; some 
appeared to be review articles that had been mistagged whereas others were very large observa-
tional studies that strictly speaking would not typically be considered to be serial case reports but 
which some journals nonetheless place in their “case report” sections.
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3.2  Case Reports on Infectious Diseases
One key role played by case reports is to draw attention to emerging or novel infec-
tious disease processes: in recent years, occurrences of Zika, Middle East Respiratory 
Syndrome (MERS), Ebola, and Influenza A have been described via case reporting, 
with attention to a range of aspects of the phenomena under study. These case 
reports often contain important data that then can journey rapidly from their loca-
tion of creation and reproduce faithfully, as long as certain features are in place.
For instance, a case report (Gao et al. 2013) of three observed human fatalities 
related to infection with a new form of the avian influenza A virus (H7N9) in 
Shanghai, China was among the most highly cited (1247 times) in the data set 
above, as the initial publication relating to what subsequently became a pandemic. 
Previously the transmission of H7 viruses to mammals had been rarely reported in 
Asia, human infection with the N9 subtype had not been documented anywhere, and 
these types of infections had rarely been fatal or as severe as in the patients who 
presented for care in Shanghai. The case report summarizes the typical information 
about the patients, including demographic and epidemiological characteristics, par-
ticularly those associated with pre-existing conditions likely to have depressed their 
immune systems as well as potential contact with chickens; the complications, treat-
ment, and clinical outcomes of the patients; and detailed analysis of the characteris-
tics of the virus isolated from the patients.
In conclusion, the authors (many of whom have numerous previous publications 
on different forms of epidemic influenza particularly in China) make an urgent call 
to others in the medical field: “We are concerned by the sudden emergence of these 
infections and the potential threat to the human population. An understanding of the 
source and mode of transmission of these infections, further surveillance, and 
appropriate counter measures are urgently required” (Gao et al. 2013, 1896). Among 
the key points discussed is whether this novel version of the virus occurred within 
these human hosts or was directly transmitted by birds, with the latter said to be the 
preferred explanation, particularly based on genetic sequencing and other forms of 
analysis. However a critical point made in the case report is that influenza surveil-
lance of birds, swine, and humans is limited in China and nearby countries, which 
makes it very difficult to provide an answer to this question.
With regard to the processes associated with data journeying, a few critical points 
are notable. First, the initial journeying of the data from the clinical setting to the 
printed case report (and hence to them becoming available publicly on a global 
basis) occurred over a highly compressed time period9: the patients were seen 
9 Case reports typically have longer gestation times between clinical observation, laboratory analy-
sis, and other processes, and actual publication, even when focused on similar public health related 
issues: see for instance Colson et al. 2010 on a small case controlled study within a single family 
on the transmission of hepatitis E via figatellu, a traditional pig liver sausage widely eaten in 
France and commonly consumed raw, where initial observations and data collection occurred in 
2007–9 but which was not published until 2010; nonetheless this case report also is among the 
most highly cited in its field.
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between mid-February and the end of March 2013, and the case report was pub-
lished online in mid-April 2013.10 Subsequently when published in print in mid- 
May, it was accompanied by a high-profile editorial by researchers at the US Centers 
for Disease Control which lauded the authors of the case report for the speed with 
which the virus was identified and whole genome sequences of it made available, 
particularly given the global public health issues raised (Uyeki and Cox 2013, which 
echoes an earlier editorial in Nature in April, Anonymous 2013), which was impor-
tant because of the lack of transparency that sometimes had occurred in the context 
of past epidemics in China (e.g., with reference to SARS, see Knobler et al. 2004). 
These factors underscore that the speed with which data from a case report journeys 
and the extent to which it travels (i.e., how often it is picked up by others reporting 
research and whether it reaches a global audience) is directly related to a number of 
factors including the perceived usefulness of the original case report in terms of the 
data contained within it and the potential threat posed by the condition(s) described, 
both of which are common in infectious disease related case reports.
Second, data within case reports are more likely to be re-used if they relate to 
multiple research methods or fields. For instance, the editorial cited above under-
scored many other critical points raised by the case report, namely that some of the 
sequence data suggested that this virus was likely to result in asymptomatic or mild 
avian disease, and thus had the potential to generate a silent widespread epizootic 
epidemic in China and neighboring countries. Many of the subsequent publications 
citing the original case report explore these types of issues (e.g., Xu et al. 2013). In 
addition, in the 6–12 months after the original case report, various members of the 
research team published more detailed reports (sometimes as research letters, pre-
sumably in order to get them published quickly given the urgency of what was 
quickly becoming a public health crisis)11 in high-profile outlets, such as on the 
biological features of the virus, epidemiological surveillance, and tracing the gene-
sis of the infection via various types of birds (e.g., Lam et al. 2013) which helped to 
widen the exposure of the original publication particularly in fields beyond infec-
tious disease. Hence various types of data originally contained within the original 
case report journeyed without necessarily being closely connected to the initial case 
report. Examples include numerous publications related to technology development 
such as new methods for real-time detection of infection (e.g., Zhu et al. 2013).
10 Although beyond the scope of this paper, it is worth noting that formal mechanisms such as infec-
tious disease reporting and more informal mechanisms such as media coverage can help data in a 
case study to journey. According to the journal Nature (Anonymous 2013), China reported the 
H7N9 outbreak to the World Health Organization (WHO) on 31 March 2013, and simultaneously 
published the genomic sequences of viruses from the three human cases on the database of the 
Global Initiative on Sharing Avian Influenza Data (GISAID). It also shared all of the sequences 
with the WHO, and live virus with the WHO and other laboratories. In addition, the Chinese media 
reported new cases on a daily basis and discussed H7N9 fairly openly, with Chinese President Xi 
Jinping publicly calling for an effective response, noting that the government should ensure release 
of accurate information about the outbreaks.
11 Self-citations are common among citations to previously published case reports, and are difficult 
to systematically eliminate from larger datasets when mapping patterns of re-use.
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Finally, the “call to arms” for more surveillance and reporting in the case report 
(and associated publications such as the accompanying editorial) resulted in numer-
ous publications about additional instances of the disease, as well as having clear 
public policy implications, which also appears to be a mark of a case report from 
which data are likely to journey. Thus potential wider relevance along with “action-
ability” of data (see Ramsden in this volume) is often associated with wider patterns 
of journeying. For instance following the case report and in part based on its find-
ings, H7N9 influenza was established as a notifiable infectious disease in Taiwan 
which experienced a spike of cases amongst travelers returning from China soon 
after the initial outbreak in China (TCDC 2013). As underscored in a paper citing 
the original case report, one of the lessons to be learned from this case report is more 
generic, and relates to the importance of this type of data having a way to journey 
outward, particularly given certain tendencies reinforced in medical training: 
“Instead of recognizing that billions of people worldwide are exposed to important 
and emerging infectious diseases, our training has relegated this topic mostly to 
‘tropical medicine’ or public health or labelled the threat as a ‘zebra’ item” (McFee 
2013), referring to the medical training adage that “if you hear hoofbeats, think 
horses, not zebras” (see Hunter 1996; Wright and Kouroukis 2000). Given increased 
globalization together with the emergence of various serious health threats, some 
“zebras” are now critically important, and there is a critical need for pandemic pre-
paredness. Thus these sorts of public health emergencies require not only rapid data 
collection and analysis, but also data sharing and feedback (Uyeki and Cox 2013; 
see also Lurie et al. 2013) via “data journeying” particularly in conceptual terms. 
Case reporting provides a clear mechanism for these processes to occur, especially 
where detailed data are provided in case reports that are useful for epidemiological 
tracking and related processes (Anonymous 2013).
3.3  Case Reporting of Adverse Effects
Another key category of case reporting relates to adverse or unexpected effects 
particularly of commonly utilized treatments or drugs. Consider a highly cited case 
report detailing two fatalities and one life-threatening incident in young children 
related to consumption of codeine for pain relief after adenotonsillectomy for 
obstructive sleep apnea syndrome (Kelly et al. 2012). The Canadian team proposed 
that where the surgery has not resolved the sleep apnea, morphine is particularly 
dangerous as it may further worsen the respiratory condition, can be fatal in cases 
where children have a certain genetic allele that can lead to a toxic accumulation of 
morphine exceeding therapeutic levels, and is of particular concern in individuals of 
North African descent where the mutation is more common (occurring in 30% of 
the population).
Some members of the team (together with the chief coroner for the province) had 
previously published a letter in 2009 focused on a single case similar to the 2012 
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series which documented the death of an otherwise healthy 2 year old with func-
tional duplication of a particular genetic allele known to be associated with increased 
rates of conversion of codeine to morphine and which may have contributed to 
respiratory depression and death, in concert with other factors (Ciszkowski et al. 
2009). In this letter, the authors declare that “given the polymorphic nature of 
codeine metabolism and the fact that adenotonsillectomy does not reverse all cases 
of obstructive sleep apnea, codeine cannot be considered a safe outpatient analgesic 
for young children after adenotonsillectomy.”
Tracing the citations to the 2012 case report reveals several key themes: first, 
the uptake of the 2009 letter (and the data contained in it) was much more lim-
ited, based on citation patterns, than the case report which appeared later, despite 
both appearing in very high-profile medical journals (The New England Journal 
of Medicine and Pediatrics respectively). However there are several reasons 
which seem to be correlated with this difference, notably that the 2012 case 
report was in fact peer-reviewed and detailed multiple instances of the observed 
phenomenon. Description of multiple occurrences of a phenomenon appears to 
result in the case report and the data contained in it being valued more highly, 
likely because it is viewed by readers as providing more or more robust evidence 
especially because other underlying factors can be ruled out; even if three cases 
may seem to many to still be anecdotal, in this example multiple cases appear to 
have resulted in more re-use of data and of the case report itself, at least in the 
form of citations.
An additional trigger which contributes to wider recognition and re-use of case 
reports is whether the observed adverse effects come to be formally certified, such 
as in recognition by regulatory authorities or professional organizations. In the cur-
rent case, during late 2011, the Patient Safety and Quality Improvement Committee 
of the American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS) 
had become concerned about adverse events, particularly respiratory depression, 
after adenotonsillectomy and conducted a nationwide, anonymous survey of otolar-
yngologists about such events (Racoosin et al. 2013). By August 2012 following an 
evaluation of the safety of use of codeine in children including a comprehensive 
review of the literature and case reports submitted to the US Food and Drug 
Administration (FDA)’s Adverse Event Reporting System, the FDA issued a press 
release and drug safety communication warning of the risk of respiratory depression 
and/or death following the use of codeine after tonsillectomy. Its review found 13 
cases, including 10 deaths and 3 cases of life-threatening respiratory depression 
associated with codeine use during the period 1969 and 1 May 2012 (including the 
original case reports). The issuing of the FDA advisory is correlated with a sharp 
increase in citations to the 2012 report, likely simply out of increased awareness of 
these issues, with many of the publications exploring implications of these findings 
for codeine use in children in this or other types of care settings.
In addition, the scale of the potential for adverse effects clearly contributes to the 
re-use of case reports. Although the complication in the case at hand is likely rare, 
it has the potential to affect a significant number of children given the huge number 
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of adenotonsillectomies performed per year, about half a million annually (Cheng 
and Sobol 2013). Case reports are more likely to be viewed as oddities or mere 
anecdotes if they seem to have very small-scale effects, in which case they are obvi-
ously not particularly ripe for re-use of the data contained within them.
A final factor about whether data contained in case reports about adverse effects 
are subsequently re-used seems to be related to whether they align with other broader 
epistemological understandings or trends in patient care, public health, or other types 
of medical practices (again here compare the chapters by Cambrosio et  al. and 
Ramsden with particular attention to the idea of actionability of data especially in 
clinical research practices). There are at least two potential ways in which these 
issues are likely have been in play in this example: first, as noted in a Perspectives 
piece published in The New England Journal of Medicine following the FDA warn-
ing, increased awareness of what they term “the value of both personalized medicine 
and the reporting of rare adverse outcomes” (Racoosin et al. 2013, 2155) has resulted 
in more attention to and publicity about such adverse effects. In other words, the 
genomic turn of the early 2000s has resulted in greater awareness of genetic diversity 
including mechanisms relating to drug reactions, and greater abilities to provide 
alternative clinical treatments. These claims are substantiated in the types of articles 
citing this case report, many of which make reference to the need for more precise 
methods to determine optimal approaches to pain control, particularly with young 
children post-adenotonsillectomy, and some of which position these claims explicitly 
within the emerging field of pharmacogenetics (e.g., Lee et al. 2014; Smith et al. 2018).
But a second likely trigger of the patterns of re-use observed relates to the 
increasing awareness of the so-called “opioid epidemic” in the 2010s, especially in 
the United States.12 Due to increases in opioid-related addiction, overdoses, and 
deaths, opioid use came to be viewed as a public health crisis in this period, in part 
related to illegal drug use but also in concert with over-prescription of legal pain 
medications including oxycodone which is chemically and otherwise similar to 
codeine. Thus in the re-use of data from the original case report, we find it cited 
simply as evidence of the potential dangers of codeine use in articles more broadly 
exploring the potential benefits and dangers of prescribing it not only for children 
(e.g., Carter et al. 2013: Martin et al. 2014) but in certain groups likely to be more 
at risk such as immigrants (e.g., Ray et  al. 2014, which in fact observed no 
increased risk in these groups despite language and genetic differences). Further, 
due to subsequent changes in the way the FDA classified (“scheduled”) hydroco-
done combination products in 2013, several of the publications (e.g., Fleming and 
Wanat 2014) emphasize the potential dangers of codeine-based products for pain 
management, in part out of recognition that there would be a tendency to increase 
use of these products as these remain accessible at levels requiring less approval 
12 Even using the terminology of “epidemic” in this context raises a range of historical, political, 
and sociological issues, but this issue is not a main focus in this paper; for discussion, see for 
instance Green et al. 2002; Martin and Martin-Granel 2006.
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processes. Hence as this case report shows, re-use of data can become quite loose 
and its journeying more akin to wandering where some part of the case report 
proves to have much broader relevance, and particularly where there are practice 
and public health implications.
4  Conclusions: Implications for Understanding How Data 
Journey
What makes data more likely to journey beyond their original case reports? It is 
clear that a few factors can be identified; though these are neither necessary or suf-
ficient, they do provide some marks that assist us with understanding the potential 
epistemological value of case reporting and the data contained within them. First, 
case reports that have implications well beyond their immediate domain are likely 
to be published in general medical journals which allows them to be read much 
more widely, and hence to much more easily be conceptualized as having broader 
relevance. Second, the data contained in case reports tend to journey when they have 
content with broader implications well beyond the case report at hand, and particu-
larly when the data have evidential value for topical or even urgent issues, particu-
larly those arising in public health. Any potential for wider applicability may well 
not be explicitly detailed in the original case report, but can be spurred on by addi-
tional factors, such as relevance for policy, uptake and endorsement by professional 
organizations or governmental authorities, description in other contexts such as 
framing editorials accompanying the case report, and so on.
Third, use of multiple research methods or concepts from diverse subfields 
within medicine can expedite the journeying of data within a case report into a range 
of types of journals and allow the data to journey well beyond their original context. 
Thus larger teams of authors are often common in the most highly cited case reports, 
likely in part because diverse expertise is necessary for case reports that bring 
together different types of data, but this pattern in turn seems to support greater 
potential for the data to journey more widely. Finally, data from case reports tend to 
journey where there is alignment with broader epistemological understandings or 
agendas within medicine: for instance the turn toward genomics in the 2000s 
resulted in journeying of data associated with numerous case reports related to 
unusual phenotypic disease patterns or adverse effects to other contexts, notably to 
publications detailing more fundamental biomedical research to determine the 
genetic basis for these patterns or effects.
What can be said about the efficiency of the journeying of data from case reports? 
The empirical data and qualitative analysis presented above reveal that the speed 
with which data from a case report journey and the extent to which they travel is cor-
related not only with the perceived usefulness of the original case report in terms of 
the original data contained within it (as would be expected) but also by the  potential 
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threat posed by the condition(s) described: so infectious disease-related case reports 
often are urgently reported and data from them picked up elsewhere. In addition, as 
occurred in the case report on the adverse effects of codeine in young tonsillectomy 
patients, data associated with case reports where broader implications subsequently 
come to be recognized (e.g., for postoperative pain control or even pain control in 
general in this example) have their journeying expedited by their application in these 
broader contexts.
These issues related to journeying take us back to the various efforts to standardize 
case reporting: why bother limiting data captured by case reports to certain categories 
when our technological infrastructures in fact might permit us to “write down every-
thing,” and in principle create more potential for journeying? One part of the answer 
clearly relates to the requirement that case reports be useable by medical practitioners 
who are both the authors of the guidelines and many of the likely users (and re-users) 
of the case reports and the data contained in them: not all data that might be captured 
and packaged in a case report are of equal relevance, which can be seen in the factors 
more closely associated with journeying outlined above. Thus new efforts at highly 
structured guidelines about what must be included impose a certain rigor to what is 
thought to be essential for understanding a case report and for re-using the data con-
tained in them to identify similar cases or other domains where the data might have 
relevance. Though in some sense it is technically possible to include absolutely all data 
(or many more pieces of data than currently contained in case reports), to do so would 
undermine the structures (narrative and otherwise) that form the basis for what the case 
report is a case of, and hence place limits on the abilities of practitioners to re-use it.
In addition, these guidelines have certain merits beyond mere standardization for 
ease of re-use of case reports and the data within them: at a deeper level, they con-
stitute a line of attack on traditional assumptions regarding what types of data are 
valued and under what circumstances. Case reporting in a standardized manner 
reinforces the value of data derived from individual case reports and helps to estab-
lish methods for consistent re-use. These types of guidelines also underscore how 
data can serve evidence in these sorts of observational settings that previously have 
been assumed to be unable to be systematized in any significant ways, particularly 
as compared to RCTs and other experimental methodologies. As the authors note, 
what is most critical is that case reporting be made more precise, complete, and 
transparent (Gagnier et al. 2013), which no doubt is correct. However as this paper 
has shown, there are deeper epistemic issues underlying the re-use of case reports 
and the journeying of the data within them, and these guidelines have the potential 
to allow both creators and users to be reflective about both the potential (and limita-
tions) of case reporting, particularly in the context of re-use.
Exploring the effective journeying of data contained in case reports together 
with efforts to standardize the presentation of data are important parts of devel-
oping deeper understandings of appropriate, effective, and rigorous ways of 
using observation- based methodologies in the biomedical sciences and other 
fields that rely on such approaches, given that these have been largely neglected, 
for instance in medicine due to the rise of EBM and related approaches in which 
data are  relatively easy to systematize (cf. Tempini and Teira in this volume on 
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the difficulties of circulating data in other settings). As the guideline authors 
state, “When it becomes clear how new data contributes to evidence, the steward-
ship needed to produce high-quality data will become more rewarding and our 
attitude toward ‘observation’ will shift…This will transform how we think about 
‘evidence’ and revolutionize its creation, diffusion, and use—opening new 
opportunity landscapes” (Gagnier et al. 2013, 5). How these types of data journey 
faithfully and efficiently in a variety of contexts and hence come to be valued as 
a form of evidence warrants further exploration.
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